info@seagull-health.com
SeagullHealth
search
Sofosbuvir and Velpatasvir Tablets(Epclusa)
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.
Epclusa(Sofosbuvir and Velpatasvir Tablets) Instructions:Uses,Dosage, Side Effects
EPCLUSA is a fixed-dose combination prescription drug containing two active ingredients, sofosbuvir and velpatasvir. It is a direct-acting antiviral medication formulated as tablets or oral pellets, designed to treat chronic hepatitis C virus (HCV) infection in adults and pediatric patients aged 3 years and older. This medication works by targeting and inhibiting specific proteins essential for the replication of the hepatitis C virus within the body.
Indicated for the treatment of adult and pediatric patients (3 years of age and older) with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infection:
Without cirrhosis or with compensated cirrhosis (Child-Pugh A).
With decompensated cirrhosis (Child-Pugh B or C) for use in combination with ribavirin.
Adults: One 400 mg/100 mg tablet orally, once daily, with or without food.
- Core products
- Antitumor drugs
- General drug
- Antiviral drugs
- Biological agents
- mailbox：info@lucius.la
